PRESS RELEASE published on 11/19/2024 at 07:30, 1 year 7 months ago Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470 Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470, dévoilant une réduction significative de la pression intraoculaire avec une concentration de 0,1 %, confirmant son choix pour les études en cours Étude Clinique Ophtalmologie Nicox NCX 470 Glaucome
BRIEF published on 10/14/2024 at 07:35, 1 year 9 months ago Nicox et Soleus signent un accord de financement de 16,5 millions de dollars Financement Nicox NCX 470 Soleus Capital VYZULTA
BRIEF published on 10/14/2024 at 07:35, 1 year 9 months ago Nicox and Soleus sign $16.5 million financing agreement Funding Nicox NCX 470 Soleus Capital VYZULTA
PRESS RELEASE published on 10/14/2024 at 07:30, 1 year 9 months ago Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres Nicox et Soleus concluent un accord de financement de 16,5 millions de dollars, combinaison de vente de redevances et fonds propres, visant à soutenir le développement du NCX 470 en ophtalmologie Accord De Financement Ophtalmologie Nicox NCX 470 Soleus
PRESS RELEASE published on 10/14/2024 at 07:30, 1 year 9 months ago Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Nicox and Soleus sign $16.5 million royalty and equity financing agreement, reducing debt burden and financing into Q3 2025. Topline results expected in Q3 2025 for NCX 470 Denali Phase 3 trial Equity Financing Nicox NCX 470 Soleus Royalty
BRIEF published on 09/18/2024 at 07:35, 1 year 9 months ago Nicox Announces Approval of ZERVIATE in China China Ophthalmology Nicox ZERVIATE Ocumension
BRIEF published on 09/18/2024 at 07:35, 1 year 9 months ago Nicox annonce l'approbation de ZERVIATE en Chine Chine Ophtalmologie Nicox ZERVIÉ Occumension
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 9 months ago Nicox Announces Approval of ZERVIATE in China Nicox announces approval of ZERVIATE in China by partner Ocumension Therapeutics for ocular itching, adding royalty revenue stream. Launch expected to boost market penetration China Approval Nicox ZERVIATE Ocular Itching
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 9 months ago Nicox annonce l’approbation de ZERVIATE en Chine Nicox annonce l’approbation de ZERVIATE, solution ophtalmique de cétirizine, pour le prurit oculaire en Chine, avec Ocumension Therapeutics. Nouvelle source de revenus pour Nicox Chine Nicox Ocumension Therapeutics ZERVIATE Prurit Oculaire
BRIEF published on 09/04/2024 at 07:35, 1 year 10 months ago Nicox nomme Christine Placet administrateur ; Michele Garufi se retire du Conseil d’administration Conseil D'administration Ophtalmologie Christine Placet Nicox Michele Garufi
Published on 07/14/2026 at 22:30, 29 minutes ago Hillcrest Energy Technologies Announces Board and Leadership Changes Following 2026 Annual General Meeting
Published on 07/14/2026 at 22:30, 29 minutes ago Loop Industries Reports First Quarter Fiscal 2027 Results and Provides Update on Progress Towards Commercialization
Published on 07/14/2026 at 16:40, 6 hours 19 minutes ago AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation
Published on 07/14/2026 at 15:45, 7 hours 14 minutes ago Silver Storm Commences Hot Commissioning of the La Parrilla Sulphide Circuit, Amends the Samsung Prepayment Agreement, and Secures US$5 Million Loan from First Majestic
Published on 07/14/2026 at 15:15, 7 hours 44 minutes ago Gratomic Inc. Provides Corporate Update for Shareholders
Published on 07/14/2026 at 19:14, 3 hours 45 minutes ago EQS-Adhoc: Nagarro SE: BaFin Enforcement Review of the 2022 Consolidated Financial Statements
Published on 07/14/2026 at 18:17, 4 hours 42 minutes ago EQS-Adhoc: Delivery Hero confirms advanced negotiations with Uber Technologies in respect to potential takeover offer
Published on 07/14/2026 at 17:51, 5 hours 8 minutes ago Aumann announces share buyback with an allotment ratio of approximately 6%
Published on 07/14/2026 at 17:30, 5 hours 29 minutes ago NABR: The U.S. Fish and Wildlife Service for the Second Time Rejects Activists' Petition to List Long-Tailed Macaque Monkeys Under the Endangered Species Act
Published on 07/14/2026 at 17:28, 5 hours 31 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 07/13/2026 at 18:00, 1 day 4 hours ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 1 day 4 hours ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 1 day 4 hours ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026